4.6 Review

HIV Treatment as Prevention: Debate and Commentary-Will Early Infection Compromise Treatment-as-Prevention Strategies?

期刊

PLOS MEDICINE
卷 9, 期 7, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pmed.1001232

关键词

-

资金

  1. National Institutes of Health (NIH) [R01 AI083059]
  2. Royal Society
  3. Medical Research Council
  4. HIV Prevention Trials Network [HPTN 052]
  5. National Institutes of Health [R37 DK049381]
  6. Center for HIV/AIDS Vaccine Immunology
  7. University of North Carolina at Chapel Hill Center for AIDS Research (CFAR)
  8. NIH [P30 AI50410]
  9. Medical Research Council [G0800596, G0600719, G0600719B] Funding Source: researchfish
  10. MRC [G0600719, G0800596] Funding Source: UKRI

向作者/读者索取更多资源

Universal HIV testing and immediate antiretroviral therapy for infected individuals has been proposed as a way of reducing the transmission of HIV and thereby bringing the HIV epidemic under control. It is unclear whether transmission during early HIV infection-before individuals are likely to have been diagnosed with HIV and started on antiretroviral therapy-will compromise the effectiveness of treatment as prevention. This article presents two opposing viewpoints by Powers, Miller, and Cohen, and Williams and Dye, followed by a commentary by Fraser.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据